Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
83 hedge funds and large institutions have $223M invested in Lumos Pharma, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 6 closing their positions.
340% more call options, than puts
Call options by funds: $53.3M | Put options by funds: $12.1M
233% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 6
17% more funds holding
Funds holding: 71 → 83 (+12)
8% more capital invested
Capital invested by funds: $206M → $223M (+$16.2M)
0% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 23
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$15.3M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$4.52M |
| 3 |
Millennium Management
New York
|
+$3.17M |
| 4 |
First Eagle Investment Management
New York
|
+$2.51M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$36.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.7M |
| 3 |
PC
PointState Capital
New York
|
-$3.46M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$867K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$248K |
LUMO Hedge Fund Activity: Q4 2013 in Review
83 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q4 2013, worth a combined $223M — up 7.9% from $206M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new LUMO positions and 6 closed out — a net gain of 14 holders — while 23 added to existing stakes and 23 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $15.3M. The largest seller was RA Capital Management, exiting entirely with an estimated $36.4M sold.
- 83 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q4 2013, up from 71 in Q3 2013.
- Funds reported $223M of Lumos Pharma, Inc. Common Stock stock for Q4 2013, up 7.9% quarter-over-quarter.
- 20 funds opened new Lumos Pharma, Inc. Common Stock positions in Q4 2013 and 6 closed out, a net change of +14 holders.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q4 2013 was Franklin Resources, an estimated $15.3M added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q4 2013 was RA Capital Management, an estimated $36.4M sold.
Based on aggregated 13F filings for Q4 2013.